Navigation Links
Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union
Date:12/16/2009

HAMBURG, Germany, December 16 /PRNewswire/ -- Eppendorf has initiated an import ban for Nanosphere, Inc.'s Verigene(R) and Verigene(R) SP systems for infringement of European patent EP 1 179 180 B2, titled "Method for the identification and/or the quantification of a target compound". The import ban covers any and all imports of the respective products into any country of the European Union. Customs authorities are required to confiscate any violating products.

The patent covers Eppendorf's Silverquant(R) microarray technology, offered in Eppendorf's Silverquant scanner and Silverquant detection kit used e.g. for Eppendorf's own microarrays. The technology is also licensed to two companies for commercialization with their microarrays.

In addition, Eppendorf has successfully initiated an import ban for the Verigene(R) kits based on the German utility model DE 20023342U1, also covering Eppendorf's Silverquant products. This ban prohibits imports into Germany either from outside the EU or from within the EU.

"Considering Nanosphere's announcement of having received the CE mark for the Verigene(R) system, Eppendorf has taken these steps to prevent the introduction of these products that are not licensed to use our patented technology into the European Union", commented Sven Bulow, Managing Director of Eppendorf Biochip Systems GmbH.

Eppendorf AG was founded in Hamburg in 1945 and has more than 2,450 employees worldwide. The company has subsidiaries in 20 countries and is represented in all other markets by distributors.

In fiscal 2008, the company's sales revenues amounted to EUR 410 million with earnings before interest and taxes (EBIT) of EUR 71.9 million.

    Contact:
    Dr. Sven Buelow
    Managing Director
    Eppendorf Biochip Systems GmbH
    Tel: +49-40-538-01-500
    Fax: +49-40-538-01-140
    '/>"/>
SOURCE Eppendorf AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. New Brunswick Scientific Completes Merger Transaction with Eppendorf
2. EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme
3. Life on Mars pregnancy test successfully launched
4. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
5. Phase I Safety and Tolerability Study With EVT 302 Successfully Completed
6. SBT Acquisition Inc. Successfully Completes Tender Offer for Shares of Lifecore Biomedical, Inc.
7. Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period
8. TopoTarget Successfully Buys Back Full Control of Belinostat
9. Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
10. Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration
11. CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement : Australia/New Zealand Regulatory-Cleared Evaluation Registry is Expected to Lead to Market Clearance for These Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... & Brussels (PRWEB) December 22, 2014 ... (CfPIE), the global leader of technical training across the ... for Clinical Data Management (SCDM) to provide the ... certification programs —providing access to the more than ... extends SCDM members with 10% off when registering for ...
(Date:12/22/2014)... SAN DIEGO , Dec. 22, 2014 ... that the Decipher Prostate Cancer Classifier, a genomic test ... disease in node-negative, high-risk men managed by radical prostatectomy ... with radical prostatectomy is relatively uncommon, using tumor genomics ... form of metastatic disease is an important advance. The ...
(Date:12/22/2014)... TENN (PRWEB) December 22, 2014 Fertility ... Donor Egg Bank USA , a network of ... country. Through this partnership, patients have fast access to ... in vitro fertilization, IVF . Fertility Associates of Memphis ... offer this fertility treatment option. , Dr. William ...
(Date:12/19/2014)... Ill. , Dec. 19, 2014 Naurex ... develop novel drugs for diseases of the central nervous ... president and chief executive officer, will present at the ... Riedel,s presentation will take place at 3:00 p.m. PST ... Francis in San Francisco, Calif. ...
Breaking Biology Technology:CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2
... BRUNSWICK, N.J., Sept. 14 Savient Pharmaceuticals, Inc. (Nasdaq: ... Food and Drug Administration (FDA) has approved KRYSTEXXA™ (pegloticase), ... treatment of chronic gout in adult patients refractory to ... therapy occurs in patients who have failed to normalize ...
... Sept. 14 DSM Biomedical , ... Berkeley based operation, DSM PTG, today announced the company ... held company specialized in developing a dynamic stabilization system ... based posterior motion preservation system for the degenerative lumbar ...
... Inc. (Nasdaq: OPTR ) announced the presentation ... fidaxomicin Phase 3 clinical trials in patients with ... Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in ... of the University of Cologne, presented data showing that ...
Cached Biology Technology:FDA Approves KRYSTEXXA™ (pegloticase) for the Treatment of Chronic Gout in Adult Patients Refractory to Conventional Therapy 2FDA Approves KRYSTEXXA™ (pegloticase) for the Treatment of Chronic Gout in Adult Patients Refractory to Conventional Therapy 3FDA Approves KRYSTEXXA™ (pegloticase) for the Treatment of Chronic Gout in Adult Patients Refractory to Conventional Therapy 4FDA Approves KRYSTEXXA™ (pegloticase) for the Treatment of Chronic Gout in Adult Patients Refractory to Conventional Therapy 5FDA Approves KRYSTEXXA™ (pegloticase) for the Treatment of Chronic Gout in Adult Patients Refractory to Conventional Therapy 6FDA Approves KRYSTEXXA™ (pegloticase) for the Treatment of Chronic Gout in Adult Patients Refractory to Conventional Therapy 7FDA Approves KRYSTEXXA™ (pegloticase) for the Treatment of Chronic Gout in Adult Patients Refractory to Conventional Therapy 8DSM Biomedical Announces Continued Partnership with Spinelab 2DSM Biomedical Announces Continued Partnership with Spinelab 3Optimer Pharmaceuticals Phase 3 Clinical Trials show Fidaxomicin is Superior to Vancomycin in Treatment of Recurrent Clostridium difficile Infection (CDI); Data Presented at ICAAC 2Optimer Pharmaceuticals Phase 3 Clinical Trials show Fidaxomicin is Superior to Vancomycin in Treatment of Recurrent Clostridium difficile Infection (CDI); Data Presented at ICAAC 3Optimer Pharmaceuticals Phase 3 Clinical Trials show Fidaxomicin is Superior to Vancomycin in Treatment of Recurrent Clostridium difficile Infection (CDI); Data Presented at ICAAC 4Optimer Pharmaceuticals Phase 3 Clinical Trials show Fidaxomicin is Superior to Vancomycin in Treatment of Recurrent Clostridium difficile Infection (CDI); Data Presented at ICAAC 5
(Date:12/17/2014)... 2014  Automation is fundamentally transforming the travel ... at international borders. Over the past decade, ePassports, ... veteran travelers to self process through border control ... at an increasing number of airports, seaports, and ... According to Maxine Most , Principal at ...
(Date:12/11/2014)... 10, 2014  That blood pressure plays a role in ... – the medical term for high blood pressure – was ... the inflatable cuff that,s used in measuring blood pressure was ... nothing new about hypertension, its triggers and its effects. In ... condition and the best ways to treat it. ...
(Date:12/10/2014)...  Wake Forest Baptist Medical Center today announced plans for ... Medicine. Funding for this $50 million capital project is ... publicly launched next summer. The medical ... series R.J. Reynolds Tobacco Company complex, adjacent to 525@vine ... with plans to be ready to welcome medical students ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... the journal Nature Structural and Molecular Biology until ... The Scripps Research Institute have shed new light on a ... to a cell,s energy needs. The studypublished February ... Nature Structural and Molecular Biology shows these recently discovered ...
... Dr. Brandon Moore, assistant professor of biological ... and Natural Sciences, has been named an Environmental ... was selected as one of only ten 2011 ... representing a number of chemical and environmental science ...
... Spanish legislation stipulates that at least 60% of waste ... of glass, 50% of metals and 22.5% of plastics. However, ... in Castelln shows that this minimum requirement is only exceeded ... depositing paper and cardboard stands at 45% in the best ...
Cached Biology News:Scripps Research study sheds light on RNA 'on/off switches' 2Scripps Research study sheds light on RNA 'on/off switches' 3Scripps Research study sheds light on RNA 'on/off switches' 4Louisiana Tech University professor named a 2011 Environmental Health Sciences Fellow 2Spanish cities fail to meet legal requirements on paper and container recycling 2
Compact, portable device, seals 96 and 384 well plates with preset temperature optimised for Eppendorf heat sealing foils and films. Suitable for plates of different heights. AC input: 50/60 Hz230 V...
Volume adapter mounts on top of the 96 well FiltrEX filter plate and allows larger volumes (1mL) to be applied to each well in a filter plate. Adapters are nonsterile....
Rabbit polyclonal to ErbB 2 (phospho Y1248) ( Abpromise for all tested applications). entrezGeneID: 2064 SwissProtID: P04626...
... multi-casting chamber is used for handcasting and vertical ... (8.3 x 7.3 cm) or precast (8.6 x ... of buffer and includes an electrophoresis tank with ... refrigerated circulator (not included), lid with power cables, ...
Biology Products: